Orient Speech Therapy
PrivateLast Round
Series D
Mar 7, 2022
Est. Valuation
$395M
Total Funding Raised
$138M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Orient Speech Therapy is a healthcare services company that provides speech and language therapy, clinical diagnosis, and therapeutic interventions for children with autism or speech disorders.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Patient Engagement, Telemedicine
Business Model
B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orient Speech Therapy Comparables
Compare Orient Speech Therapy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen Rice and Xiaomi Culture Communication | 88% | |
| Beijing Wucailu Children Development Center | 83% | |
| Beijing Peking University Medical Brain Health Technology Co., Ltd. | 80% |
Orient Speech Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 7, 2022 | ||||
| Series C Extension | Jun 25, 2021 | ||||
| Series C | Feb 5, 2021 | ||||
| Series B | Dec 18, 2017 | ||||
| Series A | Jan 1, 2015 |
Orient Speech Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series C Extension |
| Northern Light Venture Capital | Series C, Series B |
| F-Prime Capital | Series B, Series A |
| Beijing Taikang Investment Management Co., Ltd. | Series C Extension |
| Long Hill Capital | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 365% MoM, reaching 2K.
- Mar 2, 2026
Monthly visitors increased 307% MoM.
Orient Speech Therapy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orient Speech Therapy's valuation, stock price, and market status.
Is Orient Speech Therapy a public or private company?
Orient Speech Therapy is a private company.
What is the current stock price of Orient Speech Therapy?
Orient Speech Therapy is a private company with no public stock price. Caplight tracks Orient Speech Therapy's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Orient Speech Therapy worth (valuation)?
Orient Speech Therapy's valuation is estimated at $395.0M based on funding round data.
Can I buy Orient Speech Therapy stock?
Orient Speech Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orient Speech Therapy's last funding round?
Orient Speech Therapy's most recent funding round was Series D on March 7, 2022.
Who are the main investors in Orient Speech Therapy?
Key investors in Orient Speech Therapy include Temasek, Northern Light Venture Capital, F-Prime Capital, Beijing Taikang Investment Management Co., Ltd..
Will Orient Speech Therapy IPO soon?
No public IPO plans have been announced for Orient Speech Therapy.
How can I track Orient Speech Therapy secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orient Speech Therapy's secondary market activity and sign up for updates.